(Press-News.org) CLEVELAND - A recent study conducted at University Hospitals Connor Whole Health has evaluated a Reiki program designed for outpatients with cancer and receiving infusion treatments at two University Hospitals infusion centers.
The study, entitled “Evaluation of a Reiki Volunteer Program within Two Cancer Infusion Centers,” was recently published in the Journal of Pain and Symptom Management, a peer-reviewed journal that serves as an interdisciplinary audience of professionals. This retrospective review, conducted between March 2022 and February 2024, evaluated the effects of Reiki on outpatients receiving infusion treatments such as chemotherapy. During Reiki sessions, a trained practitioner generates relaxation and healing responses in the body by placing their hands on or above the body of the receiver or themselves.
Participants at the infusion clinics completed the Edmonton Symptom Assessment System (ESAS) measures for pain, fatigue, anxiety, nausea, and well-being before and after a 15–20-minute Reiki session during their infusion treatments.
The study included 392 Reiki sessions provided to 268 unique patients, with a mean age of 63.3 years. The demographic breakdown was 57.5% female, 71.6% White, and 26.5% Black/African American. The results were compelling, showing clinically significant mean improvements in all measured symptoms: pain -1.78 [95% CI: -2.38, -1.18], fatigue -1.33 [95% CI: -1.85, -0.82], anxiety -2.09 [95% CI: -2.68, -1.50], nausea -2.30 [95% CI: -2.95, -1.62], and wellbeing 1.37 [95% CI: 0.95, 1.79].
The study provided evidence for the short-term benefit of Reiki on cancer-related symptoms among outpatients receiving infusions. The participants were also highly satisfied overall with the Reiki session, demonstrating acceptability. Qualitative feedback indicated that participants experienced relaxation, symptom reduction, body sensations, emotions, gratitude, and wanted another Reiki session. Further research is needed to explore the long-term benefits of Reiki and to expand the program to more healthcare locations.
This research represents that Reiki therapy provides clinically significant improvements. The positive feedback from participants underscores the potential of Reiki as a complementary therapy in clinical settings. UH Connor Whole Health is committed to ensuring whole-person care is established and delivered for every patient.
“UH Connor Whole Health is prioritizing integrative approaches to care and producing groundbreaking research in the field, this study has provided valuable insights for the effects Reiki can have on our patients.” said Francoise Adan, MD, Chief Whole Health and Well-being Officer at UH and Director of UH Connor Whole Health.
You can read the article, “Evaluation of a Reiki Volunteer Program within Two Cancer Infusion Centers,” by clicking here.
###
Reference:
Dyer NL, Rodgers-Melnick SN, Fink KE, Rao S, Surdam J, Dusek JA. Evaluation of a Reiki Volunteer Program within Two Cancer Infusion Centers. J Pain Symptom Manage. 2024 Nov 27:S0885-3924(24)01132-1. doi: 10.1016/j.jpainsymman.2024.11.017. Epub ahead of print. PMID: 39613272.
About University Hospitals / Cleveland, Ohio
Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 21 hospitals (including five joint ventures), more than 50 health centers and outpatient facilities, and over 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship quaternary care, academic medical center, University Hospitals Cleveland Medical Center, is affiliated with Case Western Reserve University School of Medicine, Northeast Ohio Medical University, Oxford University, the Technion Israel Institute of Technology, and National Taiwan University College of Medicine. The main campus also includes the UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, with more than 3,000 active clinical trials and research studies underway. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to 19 Clinical Care Delivery and Research Institutes. UH is one of the largest employers in Northeast Ohio with more than 30,000 employees. Follow UH on LinkedIn, Facebook and Twitter. For more information, visit UHhospitals.org.
END
WHAT: A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause serious complications, even death.
These findings came from a longitudinal study funded by the National Institutes of Health (NIH) that included 6,651 U.S. adults who were followed for an average of 17 years between 2000 and 2018. Participants lived in or near one of six major metropolitan areas: New York, Baltimore, Chicago, Los Angeles, Minneapolis, and Winston-Salem, North Carolina.
Throughout the study, 248 adults, 3.7% of the study sample, developed blood clots ...
The National Academy of Inventors (NAI) is proud to announce the recipients of the inaugural Prince Mohammad bin Fahd University (PMU)-National Academy of Inventors International Patent Award. This year’s recipients will be honored at a special ceremony on December 12th, 2024 at PMU’s campus in Al-Khobar, Kingdom of Saudi Arabia.
The PMU-NAI International Patent Award was created to recognize and honor distinguished scientists, research institutions, research centers, and universities across the globe for their outstanding patents and inventions that create positive societal ...
OAK BROOK, Ill. – Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).
COPD is a group of progressive lung diseases that impair a person’s ability to breathe. Symptoms typically involve shortness of breath and fatigue. There currently is no cure for COPD, and it is the third leading cause of death worldwide, according to the World Health Organization.
A ...
Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE®) to current standard-of-care first-line maintenance therapy (following induction chemotherapy) resulted in statistically significant and clinically meaningful improvement in progression-free survival (PFS) by investigator assessment in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) metastatic ...
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
The results of this study were simultaneously published in JAMA Oncology.
“Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who ...
SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the same breast, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“Good-risk” DCIS was defined as grade 1 or 2, 2.5 cm or smaller, and having clear surgical margins of 3 mm or greater.
Current guidelines from the National Comprehensive Cancer Network (NCCN) advise that patients who undergo breast-conserving surgery after a diagnosis ...
SAN ANTONIO – Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast cancer recurrence rates as those who underwent guideline-concordant treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
The results of this study were simultaneously published in JAMA.
“Active monitoring” is a strategy in which patients are monitored closely, with surgery reserved for those patients who develop cancer.
A steady increase ...
SAN ANTONIO – Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“While post-mastectomy CWI is the standard of care for most patients with early-stage breast cancer who have four or more positive axillary lymph nodes, its role in patients with fewer positive lymph nodes or node-negative disease remains controversial,” ...
About The Study: Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the same breast at 2 years compared with those randomized to guideline-concordant care.
Corresponding Author: To contact the corresponding author, E. Shelley Hwang, MD, MPH, email shelley.hwang@duke.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.26698)
Editor’s Note: Please ...
About The Study: In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) prospective randomized trial, the overall lived experience of women randomized to undergo active monitoring for low-risk ductal carcinoma in situ was similar to that of women randomized to guideline-concordant care during the 2 years following diagnosis.
Corresponding Author: To contact the corresponding author, Ann H. Partridge, MD, MPH, email ann_partridge@dfci.harvard.edu.
To access the embargoed study: Visit our For The Media website ...
